Myositis and Pregnancy

Chapter

Abstract

The idiopathic inflammatory myopathies (IIM) are rare autoimmune disorders characterized predominantly by autoimmune inflammation within skeletal muscle with resulting clinical weakness. Pregnancy in myositis patients is rare and incompletely understood. Systematic review of myositis pregnancy reports suggests that disease activity during pregnancy (even when subclinical) may be associated with adverse pregnancy outcome. Massive deposition of fibrin in the placenta has been described in several myositis patients. Treatment during pregnancy, usually corticosteroid, appears to be associated with greater likelihood of live birth. IVIG has been used successfully and may be an effective alternative to high-dose corticosteroids.

Keywords

Arthritis Corticosteroid Tuberculosis Flare Prednisone 

References

  1. 1.
    Silva CA, Sultan SM, Isenberg DA. Pregnancy outcome in adult-onset idiopathic inflammatory myopathy. Rheumatology. 2003;42:1168–72.PubMedCrossRefGoogle Scholar
  2. 2.
    King CR, Chow S. Dermatomyositis and pregnancy. Obstet Gynecol. 1985;66:589–92.PubMedGoogle Scholar
  3. 3.
    Gutierrez G, Dagnino R, Mintz G. Polymyositis/dermatomyositis and pregnancy. Arthritis Rheum. 1984;27:291–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Tsai A, Lindheimer MD, Lamberg SI. Dermatomyositis complicating pregnancy. Obstet Gynecol. 1973;41:570–3.PubMedGoogle Scholar
  5. 5.
    Bauer K, Siegler M, Lindheimer MA. Polymyositis complicating pregnancy. Arch Intern Med. 1979;139:449.PubMedCrossRefGoogle Scholar
  6. 6.
    Katz A. Another case of polymyositis in pregnancy. Arch Intern Med. 1980;140:1123.PubMedCrossRefGoogle Scholar
  7. 7.
    England MJ, Perlmann T, Veriava Y. Dermatomyositis in pregnancy. J Reprod Med. 1986;31:633–5.PubMedGoogle Scholar
  8. 8.
    Pinheiro GRC, Goldenberg J, Atra E, Pereira RBA, Camano L, Schmidt B. Juvenile dermatomyositis: report and literature review. J Rheumatol. 1992;19:1798–801.Google Scholar
  9. 9.
    Emy P, Lenormand V, Maitre F, et al. Polymyosites à haut risque dermatomyosites et grossesse: grossesse Nouvelle observation et revue de la literature. J Gynecol Obstet Biol Reprod (Paris). 1986;15:785–90.Google Scholar
  10. 10.
    Harris A, Webley M, Usherwood M, Burge S. Dermatomyositis presenting in pregnancy. Br J Dermatol. 1995;133:783–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Solomon JE, D’Alton ME. Dermatomyositis in pregnancy. Curr Opin Obstet Gynecol. 1996;8:83–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Ishii N, Ono H, Kawagushi T, Nakajima H. Dermatomyositis and pregnancy—case report and review of the literature. Dermatologica. 1991;183:146–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Kofteridis DP, Malliotakis PI, Sotsiou F, Vardakis NK, Vamvakas LN, Emmanouel DS. Acute onset of dermatomyositis presenting in pregnancy with rhabdomyolysis and fetal loss. Scand J Rheumatol. 1999;28:192–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Satoh M, Ajmani AK, Hirakata M, Suwa A, Winfield JB, Reeves WH. Onset of polymyositis with autoanti-bodies to threonyl-tRNA synthetase during pregnancy. J Rheumatol. 1994;21:1564.PubMedGoogle Scholar
  15. 15.
    Messina S, Fagiolari G, Lamperti C, Cavaletti G, Prelle A, Scarlato G, et al. Women with pregnancy-related polymyositis and high serum CK levels in the newborn. Neurology. 2002;58:482–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Okada R, Miyabe Y, Kasai S, Hashimoto K, Yamauchi S, Yoshikawa M, Sumori K, Nagasaka K. Jpn Clin Immunol. 2010;33(3):142–8.CrossRefGoogle Scholar
  17. 17.
    Nozaki Y, Ikoma S, Funauchi M, Kinoshita K. Respiratory muscle weakness with dermatomyositis during pregnancy: successful treatment with intravenous immunoglobulin therapy. J Rheumatol. 2008;35:11.CrossRefGoogle Scholar
  18. 18.
    Linardaki G, Cherouvim E, Goni G, Boki KA. Intravenous immunoglobulin treatment for pregnancy-associated dermatomyositis. Rheumatol Int. 2011;31:113–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Vancsa A, Ponyi A, Constantin T, Zeher M, Danko K. Pregnancy outcome in idiopathic inflammatory myopathy. Rheumatol Int. 2007;27:435–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Massé MR. Grossesses et dermatomyosite. Bull Soc Fr Derm Syph. 1962;69:921–3.Google Scholar
  21. 21.
    Papapetropoulos T, Kanellakopoulou N, Tsibri E, Paschalis C. Polymyositis and pregnancy: report of a case with three pregnancies. J Neurol Neurosurg Psychiatry. 1998;64:406–22.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Al-Adnani M, Kiho L, Scheimberg I. Recurrent placental massive perivillous fibrin deposition associated with polymyositis: a case report and review of the literature. Pediatr Dev Pathol. 2008;11:226–22930.PubMedCrossRefGoogle Scholar
  23. 23.
    Steiner I, Averbuch-Heller L, Abramsky O, Raz E. Postpartum idiopathic polymyositis. Lancet. 1992;339:256.PubMedCrossRefGoogle Scholar
  24. 24.
    Ohno T, Imai A, Tamaya T. Successful outcomes of pregnancy complicated with dermatomyositis. Gynecol Obstet Invest. 1992;33:187–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Yassaee M, Kovarik CL, Werth VP. Pregnancy-associated dermatomyositis. Arch Dermatol. 2009;145(8):952–3.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Glickman FS. Dermatomyositis associated with pregnancy. U S Armed Forces Med J. 1958;9:417–25.PubMedGoogle Scholar
  27. 27.
    Houck W, Melnyk C, Gast MJ. Polymyositis in pregnancy. J Reprod Med. 1987;3:208–10.Google Scholar
  28. 28.
    Le Thi Huong D, Wechsler B, Combes R. Twin pregnancy in polymyositis. Ann Med Interne. 1988;139:286–7.Google Scholar
  29. 29.
    Rosenweig BA, Rotmensch S, Binette S, Phillippe M. Primary idiopathic polymyositis and dermatomyositis complications in pregnancy: diagnosis and treatment. Obstet Gynecol Surv. 1989;44:162–9.CrossRefGoogle Scholar
  30. 30.
    Park IW, Suh YJ, Han JH, et al. Dermatomyositis developing in the first trimester of pregnancy. Korean J Intern Med. 2003;18:196–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Mosca M, Strigini F, Carmignani A, D’ascanio A, Genazzani AR, Bombardieri S. Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy. Arthritis Rheum. 2005;53:119–21.PubMedCrossRefGoogle Scholar
  32. 32.
    Williams L, Chang PY, Park E, Gorson KC, Bayer-Zwirello L. Successful treatment of dermatomyositis during pregnancy with intravenous immunoglobulin monotherapy. Obstet Gynecol. 2007;109:561–3.PubMedCrossRefGoogle Scholar
  33. 33.
    Suwa A, Hirakata M, Tsuzaka K, et al. Spontaneous remission of dermatomyositis which developed one month after normal delivery. Ryumachi. 1992;32:73–9.PubMedGoogle Scholar
  34. 34.
    Kanoh H, Izumi T, Seishima M, Nojiri M, Ichiki Y, Kitajima Y. A case of dermatomyositis that developed after delivery: the involvement of pregnancy in the induction of dermatomyositis. Br J Dermatol. 1999;141:897–900.PubMedCrossRefGoogle Scholar
  35. 35.
    Takei R, Suzuki S, Kijima K, Sawa R, Yoneyama Y, Asakura H, et al. First presentation of polymyositis postpartum following intrauterine fetal death. Arch Gynecol Obstet. 2000;264:47.PubMedCrossRefGoogle Scholar
  36. 36.
    Hung NA, Jackson C, Nicholson M, Highton J. Pregnancy-related polymyositis and massive perivillous fibrin deposition in the placenta: are they related? Arthritis Rheum. 2006;55(1): 154–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Division of RheumatologyHospital for Special SurgeryNew YorkUSA

Personalised recommendations